ClinicalTrials.gov
public full text
Public Domain
Study to Evaluate Efficacy and Safety of Switching From TDF to TAF in Adults With Chronic Hepatitis B Who Are Virologically Suppressed
The primary objectives of this study are to evaluate the efficacy, safety, and tolerability of switching to tenofovir alafenamide (TAF) versus continuing tenofovir disoproxil fumarate (TDF) in virologically suppressed adults with chronic hepatitis B virus (HBV) infection.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Activity of NCO-48 Fumarate in Treatment-Naive Adults With Chronic Hepatitis B#1094369
- A Phase II/III of Hepenofovir Fumarate Tablets (HTS) for Chronic Hepatitis B#892820
- Treatment outcome of tenofovir disoproxil fumarate (TDF) among chronic hepatitis B patients: A retrospective review in Hospital Sultanah Nur Zahirah (HSNZ)#190819
- Clinical Efficacy and Safety of Tenofovir Disoproxil Fumarate and Entcavir in Treatment of Chronic Hepatitis B Patients in Upper Egypt#915313
- Effect of Tenofovir (TDF) on Renal Function in Patients With Chronic Hepatitis B#835151
Record · ID 843200
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive